Perrigo (PRGO) Free Cash Flow (2013 - 2026)

Perrigo's (PRGO) quarterly Free Cash Flow came in at -$127.4 million in Q1 2026, down 41.56% year-on-year from -$218.0 million in Q1 2025, and down 185.73% on a QoQ basis from $148.6 million in Q4 2025.

Perrigo (PRGO) Free Cash Flow (2013 - 2026) Analysis & Trends

Perrigo (PRGO) has 14 years of Free Cash Flow data on file, last reported at -$127.4 million in Q1 2026.

  • On a quarterly basis, Free Cash Flow fell 41.56% year-over-year to -$127.4 million in Q1 2026; TTM through Mar 2026 was $107.7 million, a 40.53% decrease from a year earlier, with the FY2025 full-year figure at $145.1 million, down 40.68% from the prior year.
  • Free Cash Flow for Q1 2026 stood at -$127.4 million, down from $148.6 million in the prior quarter.
  • Over the last five years, Free Cash Flow for PRGO reached as high as $274.9 million in Q4 2024 and fell as low as -$127.4 million in Q1 2026.
  • Historically, Free Cash Flow has averaged $45.7 million across 5 years, with a median of $32.9 million in 2023.
  • Across the five-year window, Free Cash Flow sank 597.37% in 2024 and soared 400.0% in 2025, its largest moves.
  • Year by year, Free Cash Flow stood at $99.8 million in 2022, then soared by 82.36% to $182.0 million in 2023, then surged by 51.04% to $274.9 million in 2024, then slumped by 45.94% to $148.6 million in 2025, then slumped by 185.73% to -$127.4 million in 2026.
  • Per Business Quant data, the three most recent Free Cash Flow figures were -$127.4 million in Q1 2026, $148.6 million in Q4 2025, and $29.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -208.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 291.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -373.37 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 363.70 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 348.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 144.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -38.00 Mn
10 Perrigo 1.40 Bn 1.05 Bn 325.50 Mn -127.40 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 -127.40 Mn
Mar 28, 2026 -127.40 Mn
Dec 31, 2025 148.60 Mn
Dec 31, 2025 148.60 Mn
Sep 27, 2025 29.80 Mn
Sep 27, 2025 29.80 Mn
Jun 28, 2025 56.70 Mn
Jun 28, 2025 56.70 Mn
Mar 29, 2025 -90.00 Mn
Mar 29, 2025 -90.00 Mn
Dec 31, 2024 274.90 Mn
Dec 31, 2024 274.90 Mn
Sep 28, 2024 15.10 Mn
Sep 28, 2024 15.10 Mn
Jun 29, 2024 -18.90 Mn
Jun 29, 2024 -18.90 Mn
Mar 30, 2024 -26.50 Mn
Mar 30, 2024 -26.50 Mn
Dec 31, 2023 182.00 Mn
Dec 31, 2023 182.00 Mn